Authors:
ZOBEL C
BRIXIUS K
PIETSCH M
MUNCH G
BOLCK B
SCHWINGER RHG
Citation: C. Zobel et al., UNCHANGED SARCOPLASMIC-RETICULUM CA2-ATPASE ACTIVITY, REDUCED CA2+ SENSITIVITY, AND NEGATIVE FORCE-FREQUENCY-RELATIONSHIP IN TRANSGENIC RATS OVEREXPRESSING THE MOUSE RENIN GENE(), Journal of molecular medicine, 76(7), 1998, pp. 533-544
Authors:
MUNCH G
BOLCK B
HOISCHEN S
BRIXIUS K
BLOCH W
REUTER H
SCHWINGER RHG
Citation: G. Munch et al., UNCHANGED PROTEIN EXPRESSION OF SARCOPLASMIC-RETICULUM CA2-ATPASE, PHOSPHOLAMBAN, AND CALSEQUESTRIN IN TERMINALLY FAILING HUMAN MYOCARDIUM(), Journal of molecular medicine, 76(6), 1998, pp. 434-441
Authors:
BAVENDIEK U
BRIXIUS K
MUNCH G
ZOBEL C
MULLEREHMSEN J
SCHWINGER RHG
Citation: U. Bavendiek et al., EFFECT OF INOTROPIC INTERVENTIONS ON THE FORCE-FREQUENCY RELATION IN THE HUMAN HEART, Basic research in cardiology, 93, 1998, pp. 76-85
Citation: S. Hoischen et al., T-TYPE AND L-TYPE CA2-CHANNEL ANTAGONISTS REDUCE CONTRACTILITY IN GUINEA-PIG CARDIAC MYOCYTES(), Journal of cardiovascular pharmacology, 32(2), 1998, pp. 323-330
Citation: J. Mullerehmsen et al., POSITIVE INOTROPIC EFFECTS OF THE NOVEL NA-CHANNEL MODULATOR BDF-9198IN HUMAN NONFAILING AND FAILING MYOCARDIUM(), Journal of cardiovascular pharmacology, 31(5), 1998, pp. 684-689
Citation: C. Zobel et al., EFFECT OF THE NA-CHANNEL MODULATOR BDF-9148 ON CA2+-SENSITIVITY AND FORCE OF CONTRACTION OF HYPERTROPHIC MYOCARDIUM FROM TRANSGENE RATS HARBORING THE MOUSE RENIN GENE (TG(MREN2)27)(), Naunyn-Schmiedeberg's archives of pharmacology, 357(5), 1998, pp. 532-539
Authors:
BOELCK B
MUENCH G
ZOBEL C
HOLSCHEN S
BRIXIUS K
SCHWINGER RHG
Citation: B. Boelck et al., REDUCED CA2-SENSITIVITY AND ACTIVITY OF SERCA-2 IN FAILING HUMAN MYOCARDIUM DUE TO REDUCED SERINE-16-PHOSPHOLAMBAN AND THREONINE-17-PHOSPHOLAMBAN PHOSPHORYLATION(), Circulation, 98(17), 1998, pp. 1897-1897
Authors:
BRIXIUS K
REICKE S
REUTER H
SCHWINGER RHG
Citation: K. Brixius et al., EFFECT OF THE CA2-SENSITIZERS EMD-57033 AND CGP-48506 ON THE MYOSIN-ATPASE-FORCE-RATIO IN HUMAN FAILING AND NONFAILING MYOCARDIUM(), Circulation, 98(17), 1998, pp. 3049-3049
Authors:
BRIXIUS K
MOHR V
MULLEREHMSEN J
HOISCHEN S
MUNCH G
SCHWINGER RHG
Citation: K. Brixius et al., POTENT VASODILATORY WITH MINOR CARDIODEPRESSANT ACTIONS OF MIBEFRADILIN HUMAN CARDIAC TISSUE, British Journal of Pharmacology, 125(1), 1998, pp. 41-48
Authors:
BRIXIUS K
PIETSCH M
HOISCHEN S
MULLEREHMSEN J
SCHWINGER RHG
Citation: K. Brixius et al., EFFECT OF INOTROPIC INTERVENTIONS ON CONTRACTION AND CA2+ TRANSIENTS IN THE HUMAN HEART, Journal of applied physiology, 83(2), 1997, pp. 652-660
Authors:
BRIXIUS K
ZOBEL C
MULLEREHMSEN J
REUTER H
PIETSCH M
FRANK K
SCHWINGER RHG
Citation: K. Brixius et al., THE NA-CHANNEL-MODULATORS BDF-9148 AND DPI-201-106 EXERT POSITIVE INOTROPIC EFFECT WITHOUT DIRECT INTERACTION WITH THE CONTRACTILE PROTEINSON HUMAN MYOCARDIUM(), Journal of the American College of Cardiology, 29(2), 1997, pp. 8092-8092
Authors:
SCHWINGER RHG
PIETSCH M
BRIXIUS K
MULLEREHMSEN J
Citation: Rhg. Schwinger et al., UNCHANGED FUNCTION AND DENSITY OF SR-CA2-RELEASE CHANNELS IN THE FAILING HUMAN MYOCARDIUM COMPARED TO NONFAILING(), Journal of the American College of Cardiology, 29(2), 1997, pp. 99564-99564
Authors:
MULLEREHMSEN J
FRANK K
BRIXIUS K
SCHWINGER RHG
Citation: J. Mullerehmsen et al., INCREASE IN FORCE OF CONTRACTION BY ACTIVATION OF THE NA+ CA2+-EXCHANGER IN HUMAN MYOCARDIUM/, British journal of clinical pharmacology, 43(4), 1997, pp. 399-405
Authors:
MULLEREHMSEN J
BRIXIUS K
SHULZE C
SCHWINGER RHG
Citation: J. Mullerehmsen et al., NA-FREQUENCY-RELATIONSHIP IN HUMAN MYOCARDIUM( CHANNEL MODULATION ANDFORCE), Naunyn-Schmiedeberg's archives of pharmacology, 355(6), 1997, pp. 727-732
Authors:
SCHWINGER RHG
BRIXIUS K
BAVENDIEK U
HOISCHEN S
MULLEREHMSEN J
BOLCK B
ERDMANN E
Citation: Rhg. Schwinger et al., EFFECT OF CYCLOPIAZONIC ACID ON THE FORCE-FREQUENCY-RELATIONSHIP IN HUMAN NONFAILING MYOCARDIUM, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 286-292
Authors:
BRIXIUS K
MOHR V
MULLEREHMSEN J
HOISCHEN S
SCHWINGER RHG
Citation: K. Brixius et al., THE NOVEL T-TYPE CA2-CHANNEL ANTAGONIST MIBEFRADIL EXERTS POTENT VASODILATORY EFFECTS WITHOUT REDUCING THE INTRACELLULAR SYSTOLIC CA2+-TRANSIENT AND FORCE OF CONTRACTION IN HUMAN MYOCARDIUM(), Circulation, 96(8), 1997, pp. 771-771
Citation: G. Muench et al., PHOSPHORYLATION OF PHOSPHOLAMBAN INFLUENCES CA2-2 IN FAILING AND NONFAILING HUMAN MYOCARDIUM( SENSITIVITY OF SERCA), Circulation, 96(8), 1997, pp. 1306-1306
Citation: G. Munch et al., WS-1442 (EXTRACT OF CRATAEGUS SPECIES) INCREASES FORCE OF CONTRACTIONINHUMAN FAILING MYOCARDIUM BY INHIBITION OF THE NA+ K+-ATPPASE/, Circulation, 96(8), 1997, pp. 4090-4090
Authors:
SCHWINGER RHG
REICKE S
PIETSCH M
REUTER H
MUNCH G
BRIXIUS K
Citation: Rhg. Schwinger et al., REDUCED CA2-SENSITIVITY OF FORCE GENERATION COMPARED TO MYOSIN-ATPASEACTIVITY IN FAILING HUMAN MYOCARDIUM DUE TO DILATED CARDIOMYOPATHY(), Circulation, 96(8), 1997, pp. 4230-4230
Authors:
SCHWINGER RHG
SCHULZ C
BRIXIUS K
BOHM M
MULLEREHMSEN J
ERDMANN E
Citation: Rhg. Schwinger et al., EFFECT OF EPININE ON TENSION OF HUMAN RENAL-ARTERIES, Naunyn-Schmiedeberg's archives of pharmacology, 354(3), 1996, pp. 343-347
Authors:
MULLEREHMSEN J
BRIXIUS K
HOISCHEN S
SCHWINGER RHG
Citation: J. Mullerehmsen et al., INOTROPIC AND CORONARY VASODILATORY ACTIONS OF THE K-ADENOSINE TRIPHOSPHATE CHANNEL MODULATOR NICORANDIL IN HUMAN TISSUE, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1220-1228
Authors:
SCHWINGER RHG
BAVENDIEK U
KARZCEWSKI P
HOERTER S
BOELCK B
HOISCHEN S
BRIXIUS K
KRAUSE EG
ERDMANN E
Citation: Rhg. Schwinger et al., PHOSPHORYLATION OF PHOSPHOLAMBAN INFLUENCES CA2-SENSITIVITY BUT NOT MAXIMAL CA2+ ATPASE ACTIVITY OF SERCA-II IN HUMAN MYOCARDIUM(), Circulation, 94(8), 1996, pp. 3930-3930
Authors:
SCHWINGER RHG
BOELCK B
HOERTER S
BAVENDIECK U
HOISCHEN S
MUELLEREHMSEN J
BRIXIUS K
Citation: Rhg. Schwinger et al., CA2-ATPASE ACTIVITY AND PROTEIN EXPRESSION OF THE SARCOPLASMIC-RETICULUM CA2+-ATPASE AND OF PHOSPHOLAMBAN IS ENHANCED IN RIGHT ATRIAL COMPARED TO LEFT-VENTRICULAR MYOCARDIUM IN DILATED CARDIOMYOPATHY(), Circulation, 94(8), 1996, pp. 3931-3931
Authors:
KOJDA G
BRIXIUS K
KOTTENBERG K
NIX P
SCHLUTER KD
PIPER HM
NOACK E
Citation: G. Kojda et al., THE NEW NO DONOR SPM3672 INCREASES CGMP AND IMPROVES CONTRACTION IN RAT CARDIOMYOCYTES AND ISOLATED HEART, European journal of pharmacology, 284(3), 1995, pp. 315-319